Evaluating citicoline for alcohol use disorder in adolescents
Neurobehavioral and Immune Effects of Citicoline in Youth Alcohol Use Disorder
PHASE2 · Medical University of South Carolina · NCT05870111
This study is testing whether citicoline, a supplement, can help improve brain function and recovery in young people aged 16 to 22 who are dealing with alcohol use problems.
Quick facts
| Phase | PHASE2 |
|---|---|
| Study type | Interventional |
| Enrollment | 48 (estimated) |
| Ages | 16 Years to 22 Years |
| Sex | All |
| Sponsor | Medical University of South Carolina (other) |
| Locations | 1 site (Charleston, South Carolina) |
| Trial ID | NCT05870111 on ClinicalTrials.gov |
What this trial studies
This study aims to assess the effects of citicoline, an over-the-counter supplement, compared to a placebo on the immune system, brain function, and cognitive abilities in adolescents aged 16 to 22 who may be experiencing alcohol use disorder. Participants will receive either citicoline or a placebo oral capsule, and their responses will be monitored to determine the supplement's efficacy. The study seeks to provide insights into how citicoline may influence recovery and cognitive health in young individuals dealing with alcohol-related issues.
Who should consider this trial
Good fit: Ideal candidates for this study are adolescents aged 16 to 22 who may be experiencing alcohol use disorder.
Not a fit: Patients outside the age range of 16 to 22 or those not experiencing alcohol use disorder may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could offer a new, non-invasive treatment option for adolescents struggling with alcohol use disorder.
How similar studies have performed: While there is limited data on citicoline specifically for alcohol use disorder, similar studies exploring cognitive enhancers in addiction treatment have shown promising results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion: Age 16 to 22. Call study team for additional screening and information.
Where this trial is running
Charleston, South Carolina
- Medical University of South Carolina — Charleston, South Carolina, United States (RECRUITING)
Study contacts
- Study coordinator: Cori Herring, BS
- Email: herrinco@musc.edu
- Phone: 843-792-8207
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Alcohol Use Disorder, Citicoline